CHINA PHARMA HOLDINGS, INC. Interest Expense, Customer Deposits
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Interest Expense, Customer Deposits of $105.55 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseCustomerDeposits · last filed 2023-08-14
- CHINA PHARMA HOLDINGS, INC. interest expense, customer deposits for the quarter ending 2023-06-30 was $105.55K, a 65.99% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense, customer deposits for the quarter ending 2023-03-31 was $46.02K, a 32.01% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. interest expense, customer deposits for the quarter ending 2022-06-30 was $63.59K.
- CHINA PHARMA HOLDINGS, INC. interest expense, customer deposits for the quarter ending 2022-03-31 was $67.69K.
| Period end | Interest Expense, Customer Deposits 3 month | Interest Expense, Customer Deposits 6 month |
|---|---|---|
| 2023-06-30 | $105.55K 10-Q · filed 2023-08-14 | $151.56K derived: sum of 2 quarters · filed 2023-08-14 |
| 2023-03-31 | $46.02K 10-Q · filed 2023-05-12 | |
| 2022-06-30 | $63.59K 10-Q · filed 2023-08-14 | $131.27K derived: sum of 2 quarters · filed 2023-08-14 |
| 2022-03-31 | $67.69K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |